L
Lineage Cell Therapeutics Inc
XBER:BT3
Lineage Cell Therapeutics Inc
XBER:BT3
Price:
1.35
EUR
Market Closed
Market Cap:
€395.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lineage Cell Therapeutics Inc
XBER:BT3
|
US |
|
A
|
American Eagle Outfitters Inc
F:AFG
|
US |
|
Borr Drilling Ltd
F:B2W
|
BM |
Shareholder Yield
Current shareholder yield for BT3 is .
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
BT3 Price
Lineage Cell Therapeutics Inc
Lineage Cell Therapeutics Inc
Annual Price Range
1.35
52w Low
1.01
52w High
1.64
Price Metrics
| Average Annual Return | -26.47% |
| Standard Deviation of Annual Returns | 28.1% |
| Max Drawdown | -86% |
Shares Statistics
| Market Capitalization | 263.4m EUR |
| Shares Outstanding | 292 651 390 |
| Percentage of Shares Shorted |
N/A
|
BT3 Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
BT3's latest stock split occurred on Nov 25, 2019
The company executed a 1-for-3 stock split, meaning that for every 3 shares held, investors received 1 new share.
Before the split, BT3 traded at 0.776 per share. Afterward, the share price was about 0.754.
The adjusted shares began trading on Nov 25, 2019. This was the only stock split in BT3's history.
Pre-Split Price
2.328
0.776
Post-Split Price
0.754
Before
After
